Gainers

• Firefly Neuroscience (NASDAQ:AIFF) stock rose 25.5% to $1.92 during Friday's after-market session. The company's market cap stands at $34.2 million.
• BGM Group (NASDAQ:BGM) stock increased by 25.0% to $0.75. The market value of their outstanding shares is at $182.1 million.
• Zhengye Biotechnology (NASDAQ:ZYBT) stock rose 22.54% to $0.87. The company's market cap stands at $51.6 million.
• Silexion Therapeutics (NASDAQ:SLXN) shares increased by 14.75% to $1.4. The market value of their outstanding shares is at $4.4 million. The company's, Q4 earnings came out 3 days ago.
• Milestone Scientific (AMEX:MLSS) stock increased by 13.59% to $0.28. The market value of their outstanding shares is at $22.9 million.
• CalciMedica (NASDAQ:CALC) stock increased by 9.71% to $0.63. The market value of their outstanding shares is at $10.6 million.

Losers

• Impact BioMedical (AMEX:IBO) stock fell 21.2% to $0.61 during Friday's after-market session. The market value of their outstanding shares is at $49.9 million.
• Onconetix (NASDAQ:ONCO) shares decreased by 16.94% to $0.52.
• Autonomix Medical (NASDAQ:AMIX) stock declined by 10.66% to $0.41. The company's market cap stands at $4.7 million.
• OSR Holdings (NASDAQ:OSRH) shares decreased by 8.01% to $0.4. The market value of their outstanding shares is at $11.3 million.
• HCW Biologics (NASDAQ:HCWB) shares declined by 7.48% to $0.68. The company's market cap stands at $4.3 million.
• USBC (AMEX:USBC) shares declined by 7.16% to $0.37. The market value of their outstanding shares is at $142.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.